Literature DB >> 18214160

Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastrointestinal disease.

Sigrid Grulke1, Thierry Franck, Monika Gangl, Fabrice Péters, Alexandra Salciccia, Ginette Deby-Dupont, Didier Serteyn.   

Abstract

Gastrointestinal disorders, especially strangulating intestinal obstructions, are still a major cause of illness and death in the horse. Circulating lipopolysaccharides may activate both neutrophils and monocytes. The activated neutrophils release myeloperoxidase (MPO), a specific enzyme with strong oxidative activity. The aim of this study was to evaluate MPO concentrations in the plasma and peritoneal fluid (PF) of horses with colic and to check the hypothesis that these concentrations would be higher in a case of strangulating obstruction than in cases of nonstrangulating disease. By using a specific enzyme-linked immunosorbent assay for equine MPO, we determined the MPO concentrations in horses admitted to a clinic for colic. Horses with nonstrangulating or strangulating obstruction of the large intestine (NSLI or SLI), strangulating obstruction of the small intestine (SSI), or inflammatory bowel disease (IBD) were compared with healthy horses. The horses with SLI, SSI, or IBD had significantly higher MPO levels in plasma and PF than did those in the other 2 groups. The mean plasma level was significantly higher in the horses with NSLI than in the healthy horses. High MPO values in PF indicated necrotic bowel. These results show that neutrophil activation occurs during nonstrangulating and strangulating intestinal obstruction in horses and that the plasma and PF MPO concentrations may be a marker of the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18214160      PMCID: PMC2117365     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  25 in total

1.  High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis.

Authors:  P M Suter; S Suter; E Girardin; P Roux-Lombard; G E Grau; J M Dayer
Journal:  Am Rev Respir Dis       Date:  1992-05

2.  Myeloperoxidase activity of the large intestine in an equine model of acute colitis.

Authors:  R S McConnico; D Weinstock; M E Poston; M C Roberts
Journal:  Am J Vet Res       Date:  1999-07       Impact factor: 1.156

3.  Predictive values, sensitivity and specificity of abdominal fluid variables in determining the need for surgery in horses with an acute abdominal crisis.

Authors:  S Matthews; A J Dart; S W J Reid; B A Dowling; D R Hodgson
Journal:  Aust Vet J       Date:  2002-03       Impact factor: 1.281

4.  Concentrations of serum amyloid A and lipopolysaccharide-binding protein in horses with colic.

Authors:  Michel L Vandenplas; James N Moore; Michelle H Barton; Allen J Roussel; Noah D Cohen
Journal:  Am J Vet Res       Date:  2005-09       Impact factor: 1.156

5.  Evaluation of peritoneal fluid lactate as a marker of intestinal ischaemia in equine colic.

Authors:  K M Latson; J E Nieto; P M Beldomenico; J R Snyder
Journal:  Equine Vet J       Date:  2005-07       Impact factor: 2.888

6.  Equine neutrophil myeloperoxidase in plasma: design of a radio-immunoassay and first results in septic pathologies.

Authors:  G Deby-Dupont; S Grülke; I Caudron; M Mathy-Hartert; H Benbarek; C Deby; M Lamy; D Serteyn
Journal:  Vet Immunol Immunopathol       Date:  1998-12-11       Impact factor: 2.046

7.  Detection of endotoxin in cases of equine colic.

Authors:  J N King; E L Gerring
Journal:  Vet Rec       Date:  1988-09-03       Impact factor: 2.695

8.  Neutrophil accumulation in the large colon of horses during low-flow ischemia and reperfusion.

Authors:  R M Moore; A L Bertone; M Q Bailey; W W Muir; W L Beard
Journal:  Am J Vet Res       Date:  1994-10       Impact factor: 1.156

9.  Reliability of using results of abdominal fluid analysis to determine treatment and predict lesion type and outcome for horses with colic: 218 cases (1991-1994).

Authors:  G O Freden; P J Provost; W M Rand
Journal:  J Am Vet Med Assoc       Date:  1998-10-01       Impact factor: 1.936

10.  Case-control study of the association between various management factors and development of colic in horses. Texas Equine Colic Study Group.

Authors:  N D Cohen; P L Matejka; C M Honnas; R N Hooper
Journal:  J Am Vet Med Assoc       Date:  1995-03-01       Impact factor: 1.936

View more
  4 in total

1.  Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis.

Authors:  Mahsa Moeinian; Seyedeh Farnaz Ghasemi-Niri; Shilan Mozaffari; Amir Hossein Abdolghaffari; Maryam Baeeri; Mona Navaea-Nigjeh; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Promising effect of Magliasa, a traditional Iranian formula, on experimental colitis on the basis of biochemical and cellular findings.

Authors:  Roja Rahimi; Amir Baghaei; Maryam Baeeri; Gholamreza Amin; Mohammad Reza Shams-Ardekani; Mahnaz Khanavi; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

3.  The Impact of Myeloperoxidase and Activated Macrophages on Metaphase II Mouse Oocyte Quality.

Authors:  Faten Shaeib; Sana N Khan; Mili Thakur; Hamid-Reza Kohan-Ghadr; Sascha Drewlo; Ghassan M Saed; Subramaniam Pennathur; Husam M Abu-Soud
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

4.  NDS27 combines the effect of curcumin lysinate and hydroxypropyl-β-cyclodextrin to inhibit equine PKCδ and NADPH oxidase involved in the oxidative burst of neutrophils.

Authors:  Sandrine Derochette; Ange Mouithys-Mickalad; Thierry Franck; Simon Collienne; Justine Ceusters; Ginette Deby-Dupont; Philippe Neven; Didier Serteyn
Journal:  FEBS Open Bio       Date:  2014-11-18       Impact factor: 2.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.